Transgene to Participate in HTID Conference and Investor Access Forum in Paris

information fournie par Boursorama CP •05/09/2024 à 17:45

Strasbourg, France, September 5, 2024, 5 : 45 PM CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that its management will participate in the following upcoming investor meetings taking place in Paris, France:

- 6th HealthTech Innovation Days (HTID), September 17 & 18, 2024
- Investor Access Forum, October 15 & 16, 2024


About Transgene
Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. Transgene’s programs utilize viral vector technology with the goal of indirectly or directly killing cancer cells.

.../...